Stockreport

Immunomedics teams up with AstraZeneca to evaluate Imfinzi + sacituzumab govitecan in TNBC and UC [Seeking Alpha]

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF Immunomedics teams up with AstraZeneca to evaluate Imfinzi + sacituzumab govitecan in TNBC and UC [Read more]